BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2472865)

  • 1. Nodular form of bleomycin-related pulmonary injury in patients with osteogenic sarcoma.
    Santrach PJ; Askin FB; Wells RJ; Azizkhan RG; Merten DF
    Cancer; 1989 Aug; 64(4):806-11. PubMed ID: 2472865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nodular bleomycin toxicity.
    Cohen MB; Austin JH; Smith-Vaniz A; Lutzky J; Grimes MM
    Am J Clin Pathol; 1989 Jul; 92(1):101-4. PubMed ID: 2473646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin-induced pulmonary nodules: a variant of bleomycin pulmonary toxicity.
    Zucker PK; Khouri NF; Rosenshein NB
    Gynecol Oncol; 1987 Nov; 28(3):284-91. PubMed ID: 2445636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary drug toxicity: radiologic and pathologic manifestations.
    Rossi SE; Erasmus JJ; McAdams HP; Sporn TA; Goodman PC
    Radiographics; 2000; 20(5):1245-59. PubMed ID: 10992015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin nodules mimicking metastatic osteogenic sarcoma.
    Scharstein R; Johnson JF; Cook BA; Stephenson SR
    Am J Pediatr Hematol Oncol; 1987; 9(3):219-21. PubMed ID: 2445216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic bronchiolitis obliterans organizing pneumonia with peripheral infiltrates on chest roentgenogram.
    Bartter T; Irwin RS; Nash G; Balikian JP; Hollingsworth HH
    Arch Intern Med; 1989 Feb; 149(2):273-9. PubMed ID: 2916873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation.
    Mark EJ; Ruangchira-urai R
    Ann Diagn Pathol; 2008 Jun; 12(3):171-80. PubMed ID: 18486892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic study of various lung diseases with bronchiolitis obliterans organizing pneumonia (BOOP) pattern in open lung biopsy].
    Iwata M; Sato A; Kitazawa H; Chida K; Hayakawa H; Akiyama J; Kishimoto H; Okano A; Tanguchi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Dec; 29(12):1582-90. PubMed ID: 1808381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin induced pulmonary toxicity in patients with germ cell tumours.
    Usman M; Faruqui ZS; ud Din N; Zahid KF
    J Ayub Med Coll Abbottabad; 2010; 22(3):35-7. PubMed ID: 22338413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
    Kharasch VS; Lipsitz S; Santis W; Hallowell JA; Goorin A
    Med Pediatr Oncol; 1996 Aug; 27(2):85-91. PubMed ID: 8649325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of bronchiolitis obliterans organizing pneumonia.
    Kitaichi M
    Chest; 1992 Jul; 102(1 Suppl):44S-49S. PubMed ID: 1623810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultrastructural study in the pheasant.
    Bedrossian CW; Greenberg SD; Yawn DH; O'Neal RM
    Arch Pathol Lab Med; 1977 May; 101(5):248-54. PubMed ID: 66910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchiolitis obliterans organizing pneumonia (BOOP)--chronic organized pneumonia (COP). Diagnosis, therapy and course].
    Dür P; Vogt P; Russi E
    Schweiz Med Wochenschr; 1993 Jul; 123(29):1429-38. PubMed ID: 8367701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute lung disease in the immunocompromised host: CT and pathologic examination findings.
    Brown MJ; Miller RR; Müller NL
    Radiology; 1994 Jan; 190(1):247-54. PubMed ID: 8259414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Differential diagnostic problem of distinguishing pulmonary infiltrates following bleomycin therapy from metastases].
    Mayr B; Bauer WM; Clemm C; Hartenstein R
    Rofo; 1984 Oct; 141(4):409-14. PubMed ID: 6208581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
    Mosende C; Gutierrez M; Caparros B; Rosen G
    Cancer; 1977 Dec; 40(6):2779-86. PubMed ID: 73409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary cytotoxicity induced by bleomycin and methotrexate].
    Sheĭkh ZhV; Krutskevich AO; Drebushevskiĭ NS; Shvaĭko SN; Dunaev AP; Alekseev VG
    Vestn Rentgenol Radiol; 2015; (3):46-51. PubMed ID: 26302622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant interferon-alpha2a and interferon-alphaA/D have different effects on bleomycin-induced lung injury.
    Berkman N; Kremer S; Or R; Lossos IS; Christensen TG; Goldstein RH; Breuer R
    Respiration; 2001; 68(2):169-77. PubMed ID: 11287832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings.
    Worthy SA; Flint JD; Müller NL
    Radiographics; 1997; 17(6):1359-71. PubMed ID: 9397451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
    Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
    Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.